Evidence map›Paper›PMID 41313491›Full record

ArticleEuropean journal of pediatrics2025

Characterizing the landscape of pediatric immunization schedules in the US and Europe.

Noah J Carr, Alyson Haslam

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Noah J CarrUniversity of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA. noahcarr@arizona.edu.
Alyson HaslamDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines are a cornerstone of pediatric medicine and public health. However, no prior. studies have described the similarities and differences between the pediatric immunization schedules of different countries. This study sought to characterize the landscape of general pediatric vaccine recommendations for 32 United States (US) and European, primarily high-income countries. In this cross-sectional descriptive study, pediatric vaccine schedules from 32 countries were collected from publicly accessible government websites. All recommendations for normal-risk, non-pregnant children up to and including the age of 18 were considered. 83.3% (20/24) of vaccines identified were included within at least one country's general pediatric vaccine schedule. Of these, 9 (45%) were recommended by all 32 countries. The total number of vaccines on countries' schedules ranged from 11 to 18. Twelve of 32 (37.5%) countries' schedules included at least one mandatory vaccination, with mandate frequency ranging from 7.1% to 93.8%. Among vaccines with general recommendations, 16 (84.2%) had a consistent number of doses across at least 50% of countries that included them. For most shots, there was general agreement about the age of the first recommended dose. However, numerical differences were noted for the meningococcal, Hepatitis B, and coronavirus disease 2019 (COVID-19) vaccines. Conclusion: While pediatric immunization schedules share broad similarities, including consensus on vaccine inclusion and dosing patterns, differences remain regarding mandates and timing. These findings highlight areas for further research to inform evidence-based immunization policies and national recommendations. What is known: •Pediatric immunizations provide long-term public health benefits, including reductions in infectious disease and infant mortality. •There is a relative paucity of studies comparing entire pediatric immunization schedules across countries. What is New: •This study systematically compared pediatric vaccine schedules across 32 countries, identifying which vaccines, doses, and first-dose ages are consistently recommended. •Although broad consensus was identified for many recommendations, our findings also highlight notable differences that illustrate the diversity of national immunization practices.

Indexed as

Immunization ScheduleVaccinationVaccinesAdolescentChildChild, PreschoolCOVID-19Cross-Sectional StudiesEuropeFemaleHumansInfantUnited StatesVaccinesChildhood immunizationImmunization scheduleInternational comparisonPediatric vaccinationVaccine mandatesVaccine policy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.